Trial Information

Summary: Clinical trial to test a study drug in people who have Herpes Zoster

The purpose of this study is to see if the study drug, cream, is effective on Herpes Zoster symptoms when they begin. This study will compare the study drug cream to a placebo cream, plus Valtrex (Valacyclovir) or placebo.

Study drug and study procedures will be made available to you at no cost.

To qualify, you must:

• Be at least 18 years old
• Be diagnosed with Herpes Zoster

You will not qualify if you:

• Are pregnant or breast-feeding
• Have received immunosuppressive drug therapy within the last 3 months
• Have received 5-fluorouracil, Tegafur, Capecitabine, or Doxifluridine within the last 6 month
• Have Herpes Zoster ophthalmicus
• Have a history of positive test results for hepatitis B surface antigen, hepatitis C virus or human immunodeficiency virus (HIV) antibodies
• Have participated in a clinical drug or device trial within the last 30 days

If you would like to learn more about participating in this study, please send an e-mail message using the form below.